System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Journal Article Ahead of print

PubMed: 42770835 DOI: 10.1080/14796694.2026.2721180

Plain language summary of the RELATIVITY-098 study results: nivolumab plus relatlimab given after melanoma is removed by surgery.

Future Oncol

Authors: Georgina V Long, Charlie Garnett-Benson, Sonia Dolfi, Paolo A Ascierto, Jun Guo, Ahmad A Tarhini, Sunandana Chandra, Eva Muñoz-Couselo, Michele Del Vecchio, Andreia Cristina de Melo, Margaret Callahan, Helen Gogas, Reinhard Dummer, Dirk Schadendorf, Peter Koelblinger, Gaelle Quereux, Ioannis Thomas, Jia Xin Yu, Andrew Fisher, Bonnie Wang, Patrick Djidel, Armand Chouzy, Mark Semaan, Bohang Chen, Alicia M Y Cheong, Hussein A Tawbi

Affiliations

  • aMelanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia.
  • bBristol Myers Squibb, Princeton, NJ, USA.
  • cUniversità degli Studi di Napoli 'Federico II', Napoli, Italy.
  • dIstituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Napoli, Italy.
  • ePeking University Cancer Hospital & Institute, Beijing, China.
  • fMoffitt Cancer Center & Research Institute, Tampa, FL, USA.
  • gNorthwestern University, Chicago, IL, USA.
  • hVall d'Hebron Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • iFondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • jBrazilian National Cancer Institute, Rio de Janeiro, Brazil.
  • kkMemorial Sloan Kettering Cancer Center, New York, NY, USA.
  • lNational and Kapodistrian University of Athens, Athens, Greece.
  • mUniversity of Zurich, Zurich, Switzerland.
  • nUniversity Hospital Essen, National Center for Tumor Diseases (NCT-West), Campus Essen, German Cancer Consortium, Campus Essen, and University Alliance Ruhr, Research Center One Health, University Duisburg-Essen, Essen, Germany.
  • oParacelsus Medical University, Salzburg, Austria.
  • pCHU Nantes, Nantes University and Immunology and New Concepts in ImmunoTherapy (INCIT), Nantes, France.
  • qEDOEAP, Athens, Greece.
  • rBristol Myers Squibb, Uxbridge, UK.
  • sThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.

MeSH

Language, Melanoma, Nivolumab